Unusual Clinical Presentation of Carcinoma
931
85. Chabner E, Nixon A, Gelman R, et al. Family history and treat
ment outcome in young women after breast-conserving surgery
and radiation therapy for early-stage breast cancer.
J Clin Oncol
1998;16:2045–2051.
86. Vicini FA, Kestin LL, Goldstein NS, et al. Impact of young age on out
come in patients with ductal carcinoma-in-situ treated with breast-
conserving therapy.
J Clin Oncol
2000;18:296–306.
87. Arvold ND, Taghian AG, Niemierko A, et al. Age, breast cancer sub
type approximation, and local recurrence after breast-conserving
therapy .
J Clin Oncol
2011;29:3885–3891.
88. Hughes KS, Schnaper LA, Berry D, et al. Lumpectomy plus tamoxifen
with or without irradiation in women 70 years of age or older with
early breast cancer.
N Engl J Med
2004;351:971–957.
89. Hughes KS. Lumpectomy plus tamoxifen with or without irradiation
in women 70 or older with early breast cancer. ASCO Annual Meet
ing, June 4–8, 2010, Chicago, IL. Abstract 507.
90.
, accessed July 2013.
91. Tognon C, Knezevich SR, Huntsman D, et al. Expression of the ETV6-
NTRK3 gene fusion as a primary event in human secretory breast car
cinoma.
Cancer Cell
2002;2:367–376.
92. Diallo R, Tognon C, Knezevich SR, et al. Secretory carcinoma of the
breast: a genetically defined carcinoma entity.
Verh Dtsch Ges Pathol
2003;87:193–203.
93. Litton JK, Ready K, Chen H, et al. Earlier age of onset of BRCA
mutation-related cancers in subsequent generations.
Cancer
2012;118:321–325.
94. Goodwin PJ, Phillips K-A, West DW, et al. Breast cancer prognosis in
BRCA1 and BRCA2 mutation carriers: an International Prospective
Breast Cancer Family Registry population-based cohort study.
J Clin
Oncol
2012;30:19–26.
95. Heymann S, Delaloge S, Rahal A, et al. Radio-induced malignancies
after breast cancer postoperative radiotherapy in patients with Li-
Fraumeni syndrome.
Radiat Oncol
2010;5:104.
Carcinoma in Fibroepithelial Tumors
96. Cheatle GL, Cutler M.
Tumours of the breast. Their pathology,
symptoms, diagnosis and treatment
. London: Edward Arnold & Co,
1931;483–484.
97. Harrington SW, Miller JM. Malignant changes in fibro-adenoma of
the mammary gland.
Surg Gynecol Obstet
1940;70:615–619.
98. McDivitt RW, Stewart FW, Farrow JH. Breast carcinoma arising in
solitary fibroadenomas.
Surg Gynecol Obstet
1967;125:572–576.
99. Diaz NM, Palmer JO, McDivitt RW. Carcinoma arising within fibro
adenomas of the breast. A clinicopathologic study of 105 patients.
Am
J Clin Pathol
1991;95:614–622.
100. Fondo EY, Rosen PP, Fracchia AA, et al. The problem of carcinoma
developing in a fibroadenoma. Recent experience at Memorial Hospi
tal.
Cancer
1979;43:563–567.
101. Ozzello L, Gump FE. The management of patients with carcino
mas in fibroadenomatous tumors of the breast.
Surg Gynecol Obstet
1985;160:99–103.
102. Rosen PP, Urban JA. Coexistent mammary carcinoma and cystosar
coma phyllodes.
Breast
1975;1:9–15.
103. Yoshida Y, Takaoka M, Fukumoto M. Carcinoma arising in fibroad
enoma. Case report and review of the world literature.
J Surg Oncol
1985;29:132–140.
104. Pick PW, Iossifides IA. Occurrence of breast carcinoma within a fibro
adenoma. A review.
Arch Pathol Lab Med
1984;108:590–594.
105. Borecky N, Rickard M. Preoperative diagnosis of carcinoma within
fibroadenoma on screening mammograms.
J Med Imaging Radiat On-
col
2008;52:64–67.
106. Tajima S, Kanemaki Y, Kurihara Y, et al. A case of a fibroadenoma
coexisting with an invasive lobular carcinoma in the breast.
Breast
Cancer
2011;18:319–323.
107. Baker KS, Monsees BS, Diaz NM, et al. Carcinoma within fibroadeno
mas: mammographic features.
Radiology
1990;176:371–374.
108. Gupta RK. Fine needle aspiration (FNA) cytology of concurrent breast
carcinoma in fibroadenoma.
Cytopathology
1995;6:201–203.
109. Psarianos T, Kench JG, Ung OA, et al. Breast carcinoma in a fibro
adenoma: diagnosis by fine needle aspiration cytology.
Pathology
1998;30:419–421.
62. McPherson CP, Swenson KK, Jolitz G, et al. Survival of women ages
40–49 years with breast carcinoma according to method of detection.
Cancer
1997;79:1923–1932.
63. Lannin DR, Harris RP, Swanson FH, et al. Difficulties in diagnosis of
carcinoma of the breast in patients less than fifty years of age.
Surg
Gynecol Obstet
1993;177:457–462.
64. Vetto JT, Pommier RF, Schmidt WA, et al. Diagnosis of palpable
breast lesions in younger women by the modified triple test is accurate
and cost-effective.
Arch Surg
1996;131:967–974.
65. Rosen PP, Lesser ML, Kinne DW, et al. Breast carcinoma in women
35 years of age or younger.
Ann Surg
1984;199:133–142.
66. Rosen PP, Lesser ML, Kinne DW. Breast carcinoma at the extremes
of age: a comparison of patients younger than 35 years and older than
75 years.
J Surg Oncol
1985;28:90–96.
67. Schaefer G, Rosen PP, Lesser ML, et al. Breast carcinoma in elderly
women: pathology, prognosis, and survival.
Pathol Annu
1984;19
(Pt. 1):195–219.
68. Ashkanani F, Eremin O, Heys SD. The management of cancer of the
breast in the elderly.
Eur J Surg Oncol
1998;24:396–402.
69. Collins LC, Achacoso N, Nekhlyudov L, et al. Relationship between
clinical and pathologic features of ductal carcinoma
in situ
and patient
age: an analysis of 657 patients.
Am J Surg Pathol
2009;33:1802–1808.
70. Meyer JS, Bauer WC, Rao BR. Subpopulations of breast carcinoma de
fined by S-phase fraction, morphology and estrogen receptor content.
Lab Invest
1978;39:225–235.
71. Silvestrini R, Daidore MG, Gentili C. Biologic characteristics of
breast cancer and their clinical relevance.
Commun Res Breast Dis
1981;2:1–40.
72. Gattuso P, Bloom K, Yaremko L, et al. Prognostic predictors of lymph
node metastasis in young patients with breast carcinoma.
Mod Pathol
1997;10:19A.
73. Walker RA, Lees E, Webb MB, et al. Breast carcinomas occurring in
youngwomen (
<
35 years) are different.
Br J Cancer
1996;74:1796–1800.
74. Banz-Jansen C, Heinrichs A, Hedderich M, et al. Are there changes
in characteristics and therapy of young patients with early-onset
breast cancer in Germany over the last decade?
Arch Gynecol Obstet
2013;288:379–383.
75. Dhodapkar MV, Ingle JN, Cha SS, et al. Prognostic factors in elderly
women with metastatic breast cancer treated with tamoxifen. An
analysis of patients entered on four prospective clinical trials.
Cancer
1996;77:683–690.
76. Gennari R, Curigliano G, Rotmensz N, et al. Breast carcinoma in
elderly women. Features of disease presentation, choice of local and
systemic treatments compared with younger post menopausal pa
tients.
Cancer
2004;101:1302–1310.
77. Recht A, Connolly JL, Schnitt SJ, et al. The effect of young age on tu
mor recurrence in the treated breast after conservative surgery and
radiotherapy.
Int J Radiat Oncol Biol Phys
1998;14:3–10.
78. Kurtz JM, Jacquemier J, Amalric R, et al. Why are local recurrences
after breast-conserving therapy more frequent in younger patients?
J
Clin Oncol
1990;8:591–598.
79. Fowble BL, Schultz DJ, Overmoyer B, et al. The influence of young age
on outcome and early stage breast cancer.
Int J Radiat Oncol Biol Phys
1994;30:23–33.
80. Matthews RH, McNeese MD, Montague ED, et al. Prognostic im
plications of age in breast cancer patients treated with tumorectomy
and irradiation or with mastectomy.
Int J Radiat Oncol Biol Phys
1988;14:659–663.
81. Fourquet A, Campana F, Zafrani B, et al. Prognostic factors of breast
recurrence in the conservative management of early breast cancer: a
25-year follow-up.
Int J Radiat Oncol Biol Phys
1989;17:719–725.
82. Rose MA, Henderson IC, Gelman R, et al. Premenopausal breast can
cer patients treated with conservative surgery, radiotherapy and adju
vant chemotherapy have a low risk of local failure.
Int J Radiat Oncol
Biol Phys
1989;17:711–717.
83. Haffty BG, Fischer D, Rose M, et al. Prognostic factors for local recur
rence in the conservatively treated breast cancer patient: a cautious
interpretation of the data.
J Clin Oncol
1991;9:997–1003.
84. Freedman GM, Fowble BL, Hanlon AL, et al. A close or positive mar
gin after mastectomy is not an indication for chest wall irradiation
except in women aged fifty or younger.
Int J Radiat Oncol Biol Phys
1998;41:599–605.
